Oncology

Leukemia Panel

Comprehensive Genetic Screening to Detect Leukemia-Linked Mutations

Leukemia Panel FSG
The leukemia panel test is a comprehensive genetic screening designed to detect mutations associated with various types of leukemia. It provides detailed insights into the genetic alterations that influence disease development, progression, and treatment response—helping clinicians create personalized treatment plans and monitor the disease more effectively.

Conditions Detected by Leukemia Panel

01
Acute Myeloid Leukemia (AML)
02
Acute Lymphoblastic Leukemia (ALL)
03
Chronic Myeloid Leukemia (CML)
04
Chronic Lymphocytic Leukemia (CLL)

Transforming Diagnosis and Treatment

Early Genetic Clarity

Detects disease-associated mutations even before full symptoms appear through the leukemia panel test, allowing timely intervention.

Tailored Treatment Plans

Guide therapy choices based on individual genetic profiles derived from the leukemia panel for improved outcomes.

Prognostic Insight

Understand disease aggressiveness and progression risks through key genetic markers revealed by the leukemia panel.

Monitoring & Follow-Up

Track treatment response and detect minimal residual disease with precision using insights from ongoing leukemia blood tests.

How It Works

Precise Testing for Personalized Leukemia Care

Sample Collection

Blood or bone marrow samples are collected under expert clinical guidance for the leukemia panel.

Genomic Sequencing

Next-generation sequencing is used to analyze gene mutations linked to leukemia.

Insightful Results

Receive a comprehensive report with expert interpretation and actionable clinical recommendations.

Why Choose FSG for Leukemia Testing

01

Next-Gen Sequencing
Our leukemia panel test utilizes advanced technology for high-resolution mutation profiling and rapid turnaround.

02

Expert Clinical Oversight
Hematologists and molecular pathologists review reports to ensure accurate interpretation.

03

Secure & Fast Results
Expect detailed, confidential leukemia blood test results to be delivered within days.

04

Certified UAE Leader
FSG is a pioneer in molecular diagnostics and stem cell testing, recognized for excellence across the region.
FAQ’s

Frequently Asked Questions!

We’re here to help. Explore answers or reach out to our team directly.
A leukemia panel test is a specialized diagnostic tool that analyzes genetic mutations, chromosomal abnormalities, and specific biomarkers associated with different types of leukemia. It helps identify the subtype of leukemia—such as acute lymphoblastic or acute myeloid leukemia, and guides treatment decisions based on the disease's molecular profile.
Markers that may indicate leukemia include abnormal white blood cell counts, the presence of blast cells, and genetic mutations such as BCR-ABL1, FLT3, NPM1, and TP53. A leukemia panel test often screens for these mutations and chromosomal changes like translocations to support accurate diagnosis and classification of the leukemia type.
A Complete Blood Count (CBC) may show elevated or severely low white blood cell counts, anemia, and thrombocytopenia in leukemia. While a CBC can suggest the presence of leukemia, further testing—such as a leukemia panel test—is required to confirm the diagnosis and determine its specific subtype.
A Complete Blood Count (CBC) may show elevated or severely low white blood cell counts, anemia, and thrombocytopenia in leukemia. While a CBC can suggest the presence of leukemia, further testing—such as a leukemia panel test—is required to confirm the diagnosis and determine its specific subtype.
An acute leukemia panel is a molecular test that identifies genetic mutations and rearrangements linked specifically to acute forms of leukemia, such as AML and ALL. This panel provides a comprehensive overview of leukemia's genetic profile and plays a critical role in diagnosis, risk stratification, and targeted therapy selection.

Ready to Get Started? Schedule Your Appointment

    Are You Ready? Book Appointment Now!